Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romualdo Barroso-Sousa

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Future Oncology (London, England)|June 27, 2019
Utilization of tumor genomics in clinical practice: an international survey among ASCO membersRomualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, et al.
Clinics (Sao Paulo, Brazil)|September 17, 2013
Decreased levels of alpha-1-acid glycoprotein are related to the mortality of septic patients in the emergency departmentRomualdo Barroso-Sousa, Romulo R Lobo, Patricia R Mendonça, et al.
Cancer Treatment Reviews|August 23, 2022
Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?Renata Colombo Bonadio, Paolo Tarantino, Laura Testa, et al.
JAMA Oncology|October 4, 2017
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysisRomualdo Barroso-Sousa, William T Barry, Ana C Garrido-Castro, et al.
Frontiers in Oncology|August 28, 2023
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancerSarah Sammons, Andrew Elliott, Romualdo Barroso-Sousa, et al.
Medical Oncology (Northwood, London, England)|December 19, 2014
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancerRomualdo Barroso-Sousa, Leonardo Gomes da Fonseca, Karla Teixeira Souza, et al.
Expert Review of Anticancer Therapy|December 17, 2021
Understanding resistance to immune checkpoint inhibitors in advanced breast cancerPaolo Tarantino, Romualdo Barroso-Sousa, Ana C Garrido-Castro, et al.
Thyroid : Official Journal of the American Thyroid Association|February 7, 2014
Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndromeRomualdo Barroso-Sousa, Antonio Marcondes Lerario, Joao Evangelista, et al.
Journal of Hematology & Oncology|May 7, 2017
Wnt/beta-catenin pathway: modulating anticancer immune responseSachin Gopalkrishna Pai, Benedito A Carneiro, Jose Mauricio Mota, et al.
Journal of Global Oncology|September 23, 2018
Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate CancerManuel Caitano Maia, Allan A Lima Pereira, Liana Valente Lage, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Future Oncology (London, England)|June 27, 2019
Utilization of tumor genomics in clinical practice: an international survey among ASCO membersRomualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, et al.
Clinics (Sao Paulo, Brazil)|September 17, 2013
Decreased levels of alpha-1-acid glycoprotein are related to the mortality of septic patients in the emergency departmentRomualdo Barroso-Sousa, Romulo R Lobo, Patricia R Mendonça, et al.
Cancer Treatment Reviews|August 23, 2022
Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?Renata Colombo Bonadio, Paolo Tarantino, Laura Testa, et al.
JAMA Oncology|October 4, 2017
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysisRomualdo Barroso-Sousa, William T Barry, Ana C Garrido-Castro, et al.
Frontiers in Oncology|August 28, 2023
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancerSarah Sammons, Andrew Elliott, Romualdo Barroso-Sousa, et al.
Medical Oncology (Northwood, London, England)|December 19, 2014
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancerRomualdo Barroso-Sousa, Leonardo Gomes da Fonseca, Karla Teixeira Souza, et al.
Expert Review of Anticancer Therapy|December 17, 2021
Understanding resistance to immune checkpoint inhibitors in advanced breast cancerPaolo Tarantino, Romualdo Barroso-Sousa, Ana C Garrido-Castro, et al.
Thyroid : Official Journal of the American Thyroid Association|February 7, 2014
Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndromeRomualdo Barroso-Sousa, Antonio Marcondes Lerario, Joao Evangelista, et al.
Journal of Hematology & Oncology|May 7, 2017
Wnt/beta-catenin pathway: modulating anticancer immune responseSachin Gopalkrishna Pai, Benedito A Carneiro, Jose Mauricio Mota, et al.
Journal of Global Oncology|September 23, 2018
Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate CancerManuel Caitano Maia, Allan A Lima Pereira, Liana Valente Lage, et al.
Pageof 10